Nora E Rosenberg1, Tiwonge K Mtande2, Friday Saidi2, Christopher Stanley2, Edward Jere2, Lusubiro Paile2, Kondwani Kumwenda2, Innocent Mofolo2, Wingston Ng'ambi3, William C Miller4, Irving Hoffman5, Mina Hosseinipour6. 1. UNC Project, University of North Carolina at Chapel Hill, Lilongwe, Malawi; School of Medicine, University of North Carolina at Chapel Hill, NC, USA. Electronic address: nora_rosenberg@unc.edu. 2. UNC Project, University of North Carolina at Chapel Hill, Lilongwe, Malawi. 3. Lighthouse Trust, Lilongwe, Malawi. 4. UNC Project, University of North Carolina at Chapel Hill, Lilongwe, Malawi; School of Medicine, University of North Carolina at Chapel Hill, NC, USA; School of Public Health, University of North Carolina at Chapel Hill, NC, USA. 5. UNC Project, University of North Carolina at Chapel Hill, Lilongwe, Malawi; School of Medicine, University of North Carolina at Chapel Hill, NC, USA. 6. School of Medicine, University of North Carolina at Chapel Hill, NC, USA.
Abstract
BACKGROUND:Couples HIV testing and counselling (CHTC) is encouraged but is not widely done in sub-Saharan Africa. We aimed to compare two strategies for recruiting male partners for CHTC in Malawi's option B+ prevention of mother-to-child transmission programme: invitation only versus invitation plus tracing and postulated that invitation plus tracing would be more effective. METHODS: We did an unblinded, randomised, controlled trial assessing uptake of CHTC in the antenatal unit at Bwaila District Hospital, a maternity hospital in Lilongwe, Malawi. Women were eligible if they were pregnant, had just tested HIV-positive and therefore could initiate antiretroviral therapy, had not yet had CHTC, were older than 18 years or 16-17 years and married, reported a male sex partner in Lilongwe, and intended to remain in Lilongwe for at least 1 month. Women were randomly assigned (1:1) to either the invitation only group or the invitation plus tracing group with block randomisation (block size=4). In the invitation only group, women were provided with an invitation for male partners to present to the antenatal clinic. In the invitation plus tracing group, women were provided with the same invitation, and partners were traced if they did not present. When couples presented they were offered pregnancy information and CHTC. Women were asked to attend a follow-up visit 1 month after enrolment to assess social harms and sexual behaviour. The primary outcome was the proportion of couples who presented to the clinic together and received CHTC during the study period and was assessed in all randomly assigned participants. This study is registered with ClinicalTrials.gov, number NCT02139176. FINDINGS:Between March 4, 2014, and Oct 3, 2014, 200 HIV-positive pregnant women were enrolled and randomly assigned to either the invitation only group (n=100) or the invitation plus tracing group (n=100). 74 couples in the invitation plus tracing group and 52 in the invitation only group presented to the clinic and had CHTC (risk difference 22%, 95% CI 9-35; p=0.001) during the 10 month study period. Of 181 women with follow-up data, two reported union dissolution, one reported emotional distress, and none reported intimate partner violence. One male partner, when traced, was confused about which of his sex partners was enrolled in the study. No other adverse events were reported. INTERPRETATION: An invitation plus tracing strategy was highly effective at increasing CHTC uptake. Invitation plus tracing with CHTC could have many substantial benefits if brought to scale. FUNDING: National Institutes of Health.
RCT Entities:
BACKGROUND: Couples HIV testing and counselling (CHTC) is encouraged but is not widely done in sub-Saharan Africa. We aimed to compare two strategies for recruiting male partners for CHTC in Malawi's option B+ prevention of mother-to-child transmission programme: invitation only versus invitation plus tracing and postulated that invitation plus tracing would be more effective. METHODS: We did an unblinded, randomised, controlled trial assessing uptake of CHTC in the antenatal unit at Bwaila District Hospital, a maternity hospital in Lilongwe, Malawi. Women were eligible if they were pregnant, had just tested HIV-positive and therefore could initiate antiretroviral therapy, had not yet had CHTC, were older than 18 years or 16-17 years and married, reported a male sex partner in Lilongwe, and intended to remain in Lilongwe for at least 1 month. Women were randomly assigned (1:1) to either the invitation only group or the invitation plus tracing group with block randomisation (block size=4). In the invitation only group, women were provided with an invitation for male partners to present to the antenatal clinic. In the invitation plus tracing group, women were provided with the same invitation, and partners were traced if they did not present. When couples presented they were offered pregnancy information and CHTC. Women were asked to attend a follow-up visit 1 month after enrolment to assess social harms and sexual behaviour. The primary outcome was the proportion of couples who presented to the clinic together and received CHTC during the study period and was assessed in all randomly assigned participants. This study is registered with ClinicalTrials.gov, number NCT02139176. FINDINGS: Between March 4, 2014, and Oct 3, 2014, 200 HIV-positive pregnant women were enrolled and randomly assigned to either the invitation only group (n=100) or the invitation plus tracing group (n=100). 74 couples in the invitation plus tracing group and 52 in the invitation only group presented to the clinic and had CHTC (risk difference 22%, 95% CI 9-35; p=0.001) during the 10 month study period. Of 181 women with follow-up data, two reported union dissolution, one reported emotional distress, and none reported intimate partner violence. One male partner, when traced, was confused about which of his sex partners was enrolled in the study. No other adverse events were reported. INTERPRETATION: An invitation plus tracing strategy was highly effective at increasing CHTC uptake. Invitation plus tracing with CHTC could have many substantial benefits if brought to scale. FUNDING: National Institutes of Health.
Authors: Erik J Schouten; Andreas Jahn; Dalitso Midiani; Simon D Makombe; Austin Mnthambala; Zengani Chirwa; Anthony D Harries; Joep J van Oosterhout; Tarek Meguid; Anne Ben-Smith; Rony Zachariah; Lutgarde Lynen; Maria Zolfo; Wim Van Damme; Charles F Gilks; Rifat Atun; Mary Shawa; Frank Chimbwandira Journal: Lancet Date: 2011-07-16 Impact factor: 79.321
Authors: Myron S Cohen; Ying Q Chen; Marybeth McCauley; Theresa Gamble; Mina C Hosseinipour; Nagalingeswaran Kumarasamy; James G Hakim; Johnstone Kumwenda; Beatriz Grinsztejn; Jose H S Pilotto; Sheela V Godbole; Sanjay Mehendale; Suwat Chariyalertsak; Breno R Santos; Kenneth H Mayer; Irving F Hoffman; Susan H Eshleman; Estelle Piwowar-Manning; Lei Wang; Joseph Makhema; Lisa A Mills; Guy de Bruyn; Ian Sanne; Joseph Eron; Joel Gallant; Diane Havlir; Susan Swindells; Heather Ribaudo; Vanessa Elharrar; David Burns; Taha E Taha; Karin Nielsen-Saines; David Celentano; Max Essex; Thomas R Fleming Journal: N Engl J Med Date: 2011-07-18 Impact factor: 91.245
Authors: Lillian B Brown; William C Miller; Gift Kamanga; Naomi Nyirenda; Pearson Mmodzi; Audrey Pettifor; Rosalie C Dominik; Jay S Kaufman; Clement Mapanje; Francis Martinson; Myron S Cohen; Irving F Hoffman Journal: J Acquir Immune Defic Syndr Date: 2011-04-15 Impact factor: 3.731
Authors: Robert Byamugisha; Anne N Åstrøm; Grace Ndeezi; Charles A S Karamagi; Thorkild Tylleskär; James K Tumwine Journal: J Int AIDS Soc Date: 2011-09-13 Impact factor: 5.396
Authors: Nora E Rosenberg; Lauren A Graybill; Austin Wesevich; Nuala McGrath; Carol E Golin; Suzanne Maman; Mercy Tsidya; Limbikani Chimndozi; Irving F Hoffman; Mina C Hosseinipour; William C Miller Journal: AIDS Behav Date: 2018-06
Authors: Nora E Rosenberg; Lauren A Graybill; Austin Wesevich; Nuala McGrath; Carol E Golin; Suzanne Maman; Nivedita Bhushan; Mercy Tsidya; Limbikani Chimndozi; Irving F Hoffman; Mina C Hosseinipour; William C Miller Journal: J Acquir Immune Defic Syndr Date: 2017-08-01 Impact factor: 3.731
Authors: Jennifer Mark; John Kinuthia; Alison C Roxby; Daisy Krakowiak; Alfred Osoti; Barbra A Richardson; Molly Ann Gone; Victor Asila; Saloni Parikh; Carey Farquhar Journal: Sex Transm Dis Date: 2017-09 Impact factor: 2.830
Authors: Euphemia L Sibanda; Mary Tumushime; Juliet Mufuka; Sue Napierala Mavedzenge; Stephano Gudukeya; Sergio Bautista-Arredondo; Karin Hatzold; Harsha Thirumurthy; Sandra I McCoy; Nancy Padian; Andrew Copas; Frances M Cowan Journal: Lancet Glob Health Date: 2017-09 Impact factor: 26.763
Authors: Blake M Hauser; William C Miller; Hannock Tweya; Colin Speight; Tiwonge Mtande; Sam Phiri; L M Ball; Mina C Hosseinipour; Irving F Hoffman; Nora E Rosenberg Journal: Int J STD AIDS Date: 2017-07-27 Impact factor: 1.359
Authors: Lisa Abuogi; Karen Hampanda; Tobias Odwar; Anna Helova; Thomas Odeny; Maricianah Onono; Elizabeth Bukusi; Janet Turan Journal: AIDS Care Date: 2019-09-05
Authors: Jennifer Mark; John Kinuthia; Alfred O Osoti; Molly A Gone; Victor Asila; Daisy Krakowiak; Monisha Sharma; Saloni Parikh; Quy T Ton; Barbra A Richardson; Carey Farquhar; Alison C Roxby Journal: Sex Transm Dis Date: 2019-11 Impact factor: 2.830
Authors: Adam R Aluisio; Rose Bosire; Betz Bourke; Ann Gatuguta; James N Kiarie; Ruth Nduati; Grace John-Stewart; Carey Farquhar Journal: J Acquir Immune Defic Syndr Date: 2016-10-01 Impact factor: 3.731